Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 1
2004 7
2005 5
2006 7
2007 13
2008 14
2009 11
2010 12
2011 8
2012 10
2013 13
2014 13
2015 15
2016 30
2017 29
2018 22
2019 21
2020 15
2021 9
2022 8
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Results by year

Filters applied: . Clear all
Page 1
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: katayama n. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, Nishikori M, Ohata K, Sunami K, Yoshida I, Yamamoto G, Takahashi N, Okamoto M, Yano H, Nishimura Y, Tamaru S, Nishikawa M, Izutsu K, Kinoshita T, Suzumiya J, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: katayama n. Haematologica. 2020 Sep 1;105(9):2308-2315. doi: 10.3324/haematol.2019.231076. Haematologica. 2020. PMID: 33054055 Free PMC article. Clinical Trial.
Ontogeny of human B1 cells.
Kageyama Y, Katayama N. Kageyama Y, et al. Among authors: katayama n. Int J Hematol. 2020 May;111(5):628-633. doi: 10.1007/s12185-019-02775-y. Epub 2019 Nov 12. Int J Hematol. 2020. PMID: 31721035 Review.
Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Wada H, Matsumoto T, Katayama N. Wada H, et al. Among authors: katayama n. N Engl J Med. 2017 Nov 30;377(22):2193-4. doi: 10.1056/NEJMc1712683. N Engl J Med. 2017. PMID: 29188947 No abstract available.
[Blood cell generation from iPS cells].
Katayama N. Katayama N. Rinsho Ketsueki. 2014 Oct;55(10):1795-802. Rinsho Ketsueki. 2014. PMID: 25297742 Review. Japanese. No abstract available.
Photo-induced semimetallic states realised in electron-hole coupled insulators.
Okazaki K, Ogawa Y, Suzuki T, Yamamoto T, Someya T, Michimae S, Watanabe M, Lu Y, Nohara M, Takagi H, Katayama N, Sawa H, Fujisawa M, Kanai T, Ishii N, Itatani J, Mizokawa T, Shin S. Okazaki K, et al. Among authors: katayama n. Nat Commun. 2018 Oct 17;9(1):4322. doi: 10.1038/s41467-018-06801-1. Nat Commun. 2018. PMID: 30333495 Free PMC article.
A bifurcation concept for B-lymphoid/plasmacytoid dendritic cells with largely fluctuating transcriptome dynamics.
Nagaharu K, Kojima Y, Hirose H, Minoura K, Hinohara K, Minami H, Kageyama Y, Sugimoto Y, Masuya M, Nii S, Seki M, Suzuki Y, Tawara I, Shimamura T, Katayama N, Nishikawa H, Ohishi K. Nagaharu K, et al. Among authors: katayama n. Cell Rep. 2022 Aug 30;40(9):111260. doi: 10.1016/j.celrep.2022.111260. Cell Rep. 2022. PMID: 36044861 Free article.
233 results